Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Hepatocellular × obinutuzumab × 90 days × Clear all

Sponsor

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 22 Lymphoma, Non-Hodgkin 10 Lymphoma, Follicular 8 Lymphoma 7 Lymphoma, Mantle-Cell 6 Lymphoma, Large B-Cell, Diffuse 5 Recurrence 4 Neoplasms 3 Lymphoma, B-Cell, Marginal Zone 3 Lymphoma, B-Cell 3 Leukemia, Hairy Cell 2 Leukemia 2 Burkitt Lymphoma 2 Neoplasm, Residual 1 Lymphatic Diseases 1 Leukemia, B-Cell 1 Heart Failure 1 Extensive Stage Small Cell Lung Cancer 1 Dendritic Cell Sarcoma, Interdigitating 1 Cytokine Release Syndrome 1

Interventions

Bevacizumab 24 atezolizumab 19 durvalumab 18 Specimen Handling 15 pembrolizumab 12 lenvatinib 11 Magnetic Resonance Spectroscopy 11 tremelimumab 10 Nivolumab 10 Sorafenib 8 Radiosurgery 8 Cyclophosphamide 6 camrelizumab 5 apatinib 5 Ipilimumab 5 tislelizumab 4 regorafenib 4 fludarabine 4 cabozantinib 4 X-Rays 4 Immunoglobulin G 4 sintilimab 3 gadolinium ethoxybenzyl DTPA 3 Immune Checkpoint Inhibitors 3 Ethiodized Oil 3 E-7386 3 Disulfides 3 Blood Specimen Collection 3 Biopsy 3 gadobutrol 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡